Clinical meaning
The NP must master the iron studies panel as an integrated diagnostic tool rather than interpreting individual values in isolation. The core iron panel includes serum iron, total iron binding capacity (TIBC), transferrin saturation (TSAT), and serum ferritin, each reflecting different aspects of iron metabolism. Serum iron measures the concentration of iron bound to transferrin in the plasma at the time of sampling; it has significant diurnal variation (highest in the morning, lowest in the evening with a 30-50% swing), is acutely affected by recent iron intake, and drops rapidly during acute infection or inflammation as part of the innate immune response to sequester iron from pathogens. TIBC is an indirect measure of transferrin concentration in the serum: since each transferrin molecule binds two iron atoms, TIBC reflects the total plasma iron-carrying capacity. The liver regulates transferrin synthesis inversely to iron stores -- in iron deficiency, the liver upregulates transferrin production (increasing TIBC) to maximize iron scavenging; in iron overload, transferrin synthesis decreases (decreasing TIBC). Transferrin saturation (TSAT) is calculated as (serum iron / TIBC) x 100 and represents the percentage of available transferrin binding sites occupied by iron; TSAT less than 20% indicates insufficient iron delivery to the bone marrow for erythropoiesis (functional iron deficiency), while TSAT greater than 45% suggests iron overload and warrants evaluation for hemochromatosis. Serum ferritin is the most sensitive single test for iron deficiency (reflecting total body iron stores), but its critical limitation is that it is an acute phase reactant elevated by inflammation (IL-6 and IL-1 stimulate ferritin synthesis), infection, liver disease, malignancy, and metabolic syndrome independent of iron status. A ferritin less than 30 ng/mL is diagnostic of iron deficiency regardless of clinical context; however, in the setting of chronic inflammation, a ferritin up to 100 ng/mL may still represent iron deficiency. Advanced iron studies include soluble transferrin receptor (sTfR), which reflects erythroid iron demand and is elevated when erythroid precursors are iron-starved -- critically, sTfR is NOT affected by inflammation, making it invaluable for distinguishing IDA from ACD. The sTfR/log ferritin ratio (Thomas plot) greater than 2 strongly supports iron deficiency even in inflammatory states. Reticulocyte hemoglobin content (CHr or Ret-He) measures the hemoglobin content of newly produced reticulocytes, providing a real-time snapshot of iron availability for erythropoiesis over the preceding 24-48 hours; CHr less than 28 pg indicates iron-restricted erythropoiesis and is the EARLIEST marker of functional iron deficiency, detectable before MCV or hemoglobin changes.